Recent

% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. Message Board

  • yrubinek yrubinek Dec 29, 2013 5:31 AM Flag

    Keith S. Ehrlich - SNTA Chief Financial Officer, Principal Accounting Officer and Vice President of Administration & Finance

    "The discussions are, we're in advance discussions. They're going well. We were certainly -- a lot of us were waiting for the World Lung data. I think as Vojo mentioned, we're very encouraged by the positive reception in Sydney to the data in the Lung Community. And I think that will have a positive impact, although I think most expectations on the data are consistent before and after that meeting. Beyond that, I couldn't really give any guidance on timing. We've never really guided on-timing discussions. In addition, we continue to look at all -- we always look opportunistically at all options.

 
SNTA
2.09+0.02(+0.97%)Aug 4 4:00 PMEDT